相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients
Julie N. Graff et al.
CLINICAL GENITOURINARY CANCER (2015)
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Roberta Ferraldeschi et al.
EUROPEAN UROLOGY (2015)
Inflammation and prostate cancer: friends or foe?
Gianluigi Taverna et al.
INFLAMMATION RESEARCH (2015)
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy
Tanja Langsenlehner et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials
R. J. van Soest et al.
ANNALS OF ONCOLOGY (2015)
Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer
Xiaoan Liu et al.
CARCINOGENESIS (2015)
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
Luca Faloppi et al.
BMC CANCER (2014)
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
M. H. Kang et al.
BRITISH JOURNAL OF CANCER (2014)
Simple Prognostic Score for Metastatic Castration-Resistant Prostate Cancer With Incorporation of Neutrophil-to-Lymphocyte Ratio
Arnoud J. Templeton et al.
CANCER (2014)
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
Tomohiro Yamaguchi et al.
CANCER SCIENCE (2014)
Prognostic Significance of Pretreatment Laboratory Parameters in Combined Small-Cell Lung Cancer
Xinyue Wang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
Han Xie et al.
CELL METABOLISM (2014)
Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer
Guru Sonpavde et al.
CLINICAL GENITOURINARY CANCER (2014)
Metabolic Activity on [18F]-FluorodeoxyglucosePositron Emission Tomography/Computed Tomography and Glucose Transporter-1 Expression Might Predict Clinical Outcomes in Patients With Limited Disease Small-Cell Lung Cancer Who Receive Concurrent Chemoradiation
Jieun Lee et al.
CLINICAL LUNG CANCER (2014)
Initial metastatic kinetics is the best prognostic indicator in stage IV metastatic melanoma
Caroline Gaudy-Marqueste et al.
EUROPEAN JOURNAL OF CANCER (2014)
Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice
Tomomi Kamba et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma
Bulent Cetin et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
Bradley J. Atkinson et al.
JOURNAL OF UROLOGY (2014)
Long-Term Follow-Up and Prognostic Factors for Advanced Thymic Carcinoma
Jun-xin Wu et al.
MEDICINE (2014)
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials
David J. Pinato et al.
PLOS ONE (2014)
Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
Lei Zeng et al.
PLOS ONE (2014)
A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
Arife Ulas et al.
PLOS ONE (2014)
Metastatic Melanoma: Lactate Dehydrogenase Levels and CT Imaging Findings of Tumor Devascularization Allow Accurate Prediction of Survival in Patients Treated with Bevacizumab
Mark R. Gray et al.
RADIOLOGY (2014)
Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus
Robert J. Amato et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area
Zhengbo Wei et al.
ONCOTARGETS AND THERAPY (2014)
S-100B: A Stronger Prognostic Biomarker than LDH in Stage IIIB-C Melanoma
K. P. Wevers et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The liberated domain I of urokinase plasminogen activator receptor a new tumour marker in small cell lung cancer
Charlotte E. Almasi et al.
APMIS (2013)
Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration- Resistant Prostate Cancer
A. J. Armstrong et al.
CLINICAL CANCER RESEARCH (2013)
High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma
Xiang-bo Wan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy
Y. Jin et al.
EUROPEAN JOURNAL OF CANCER (2013)
Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms
Aurelius Omlin et al.
EUROPEAN UROLOGY (2013)
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
Michael Haas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Prognostic impact of LDH levels in patients with relapsed/refractory seminoma
Tom Powles et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment
Yun-Ming Tian et al.
RADIATION ONCOLOGY (2013)
LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis
Zhi-Yu Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
M. Scartozzi et al.
BRITISH JOURNAL OF CANCER (2012)
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
B. Weide et al.
BRITISH JOURNAL OF CANCER (2012)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer
Shintaro Narita et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Baseline Serum Lactate Dehydrogenase Levels for Patients Treated With Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Predictor of Poor Prognosis and Subsequent Liver Metastasis
Guan-Qun Zhou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
LDH-C4: a target with therapeutic potential for cancer and contraception
G. S. Gupta
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma
Guo Li et al.
CHINESE JOURNAL OF CANCER (2012)
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
S. Patil et al.
ANNALS OF ONCOLOGY (2011)
Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
S. L. Richey et al.
ANNALS OF ONCOLOGY (2011)
Validation of prognostic scores for survival in cancer patients beyond first-line therapy
Olivier Tredan et al.
BMC CANCER (2011)
Evidence for a stromal-epithelial lactate shuttle in human tumors MCT4 is a marker of oxidative stress in cancer-associated fibroblasts
Diana Whitaker-Menezes et al.
CELL CYCLE (2011)
Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: A retrospective analysis
S. Sougioultzis et al.
EJSO (2011)
Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib
E. Jason Abel et al.
EUROPEAN UROLOGY (2011)
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib
Hai-Liang Zhang et al.
INTERNATIONAL JOURNAL OF UROLOGY (2011)
Docetaxel as a vital option for corticosteroid-refractory prostate cancer
Haruki Kume et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2011)
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells
Carlotta Granchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
Benoist Chibaudel et al.
ONCOLOGIST (2011)
Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer
Yoshiaki Yamada et al.
ONCOLOGY REPORTS (2011)
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
J. S. Vermaat et al.
ANNALS OF ONCOLOGY (2010)
All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer
F. A. W. Coumans et al.
ANNALS OF ONCOLOGY (2010)
Determinants of survival in patients with brain metastases from cutaneous melanoma
M. Staudt et al.
BRITISH JOURNAL OF CANCER (2010)
Can We Better Select Patients With Metastatic Renal Cell Carcinoma for Cytoreductive Nephrectomy?
Stephen H. Culp et al.
CANCER (2010)
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Andrew J. Armstrong et al.
CLINICAL CANCER RESEARCH (2010)
Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy
Marco Gerlinger et al.
EUROPEAN JOURNAL OF CANCER (2010)
Impact of S-1 in Patients with Gemcitabine-refractory Pancreatic Cancer in Japan
Yousuke Nakai et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
Junji Furuse et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma
Enrique Gonzalez-Billalabeitia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis
D. Trivanovic et al.
CLINICAL ONCOLOGY (2009)
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer
Han Xie et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
Olivier Feron
RADIOTHERAPY AND ONCOLOGY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
A single-institution validation of the AJCC staging system for stage IV melanoma
Heather B. Neuman et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
CANCER (2008)
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Pierre Sonveaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy:: New paradigm from a large phase III trial with shark cartilage extract AE 941
Bernard Escudier et al.
JOURNAL OF UROLOGY (2007)
Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer
Toshihiro Saito et al.
UROLOGY (2007)
Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer
Wouter K. de Jong et al.
CLINICAL LUNG CANCER (2007)
Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis
MR van Dijk et al.
EUROPEAN JOURNAL OF CANCER (2006)
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma
F Donskov et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma
H Schmidt et al.
CANCER (2006)
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480
Peter A. Humphrey et al.
CLINICAL GENITOURINARY CANCER (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
J Peccatori et al.
CANCER (2005)
Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer
AV D'Amico et al.
UROLOGY (2005)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
H Schmidt et al.
BRITISH JOURNAL OF CANCER (2005)
Prognostic significance of plasma chromogranin A levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
ME Taplin et al.
UROLOGY (2005)
Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study
C Soubrane et al.
MELANOMA RESEARCH (2005)
Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma
T Masaki et al.
CANCER (2005)
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480
DJ George et al.
CLINICAL CANCER RESEARCH (2005)
An evidence-based staging system for cutaneous melanoma
CM Balch et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
V Chiarion-Sileni et al.
EUROPEAN JOURNAL OF CANCER (2003)
Metastatic renal carcinoma comprehensive prognostic system
J Atzpodien et al.
BRITISH JOURNAL OF CANCER (2003)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
